Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China

Saturday, January 30, 2021

Amgen announced that its investigational KRASGC inhibitor sotorasib was granted Breakthrough Therapy Designation BTD by the Center for Drug Evaluation CDE of the National Medical Products Administration NMPA

OSE Immunotherapeutics Expands its Collaboration with MAbSilico to Use Artificial Intelligence to Accelerate Drug Development of Novel Antibody Therapeutics

Thursday, January 28, 2021

OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico a deep technology innovative TechBio located in Tours France to use artificial intelligence AIbased software for therapeutic monoclonal antibody drug development Nicolas Po...

Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (T1D)

Thursday, January 28, 2021

Vertex Pharmaceuticals Incorporated announced that the US Food and Drug Administration FDA has cleared the IND enabling the company to proceed with initiating a clinical trial for VX an investigational stem cellderived fully differentiated pancreatic...

OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical Study

Thursday, January 28, 2021

OmniSeq an innovator in next generation sequencing in oncology today announced its collaboration with the University of Pittsburgh Medical Center UPMC to employ its RNA sequencing RNAseq gene expression profile assay for selecting immunotherapy combi...

Takeda Presents Positive Results for Mobocertinib in Patients with EGFR Exon20 Insertion+ mNSCLC who Received Prior Platinum-Based Chemotherapy

Thursday, January 28, 2021

Takeda Pharmaceutical Company Limited announced new data from the Phase trial of mobocertinib TAK orally administered in previously treated patients with epidermal growth factor receptor EGFR Exon insertion metastatic nonsmall cell lung cancer mNSCL...

Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®

Thursday, January 28, 2021

BioThera Solutions a commercialstage biopharmaceutical company today announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for BAT a proposed biosimilar to Avastin bevacizumab The FDA goal date set...

Almirall and Happify Health enter into strategic partnership to develop evidence-supported digital therapeutics solutions for psoriasis patients

Friday, January 29, 2021

Almirall SA a global biopharmaceutical company based in Barcelona and Happify Health a leader in digital therapeutics solutions to improve mental and physical health based in New York will develop a version of its digital platform specifically for pe...

ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital

Wednesday, January 27, 2021

ADVANZ PHARMA Corp Limited ADVANZ PHARMA or the Company a specialty pharmaceutical company with a strategic focus on complex medicines in Europe today announced that its board of directors has reached an agreement on the terms of a cash offer to be m...

Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM

Wednesday, January 27, 2021

Antengene Corporation Limited Antengene SEHK HK a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestin class therapeutics in hematology and oncology announced that the N...

Q BioMed’s Uttroside-B Receives U.S. FDA Orphan Drug Designation in the Treatment of Liver Cancer

Wednesday, January 27, 2021

Q BioMed Inc announced that the US Food and Drug Administrations Office of Orphan Products Development has granted Orphan Drug Designation to UttrosideB a small molecule chemotherapeutic for the treatment of hepatocellular carcinoma HCC the most comm...